Agilent (NYSE: A) director granted 2,158 fully vested common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Rataj Sue H. reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. director Sue H. Rataj received an award of 2,158 shares of common stock on March 19, 2026. The shares were granted as compensation for service as a non-employee director and were fully vested upon grant at a reference price of $111.75 per share. Following this award, she directly holds 23,617 shares of Agilent common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rataj Sue H.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,158 | $111.75 | $241K |
Holdings After Transaction:
Common Stock — 23,617 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Agilent (A) report for director Sue H. Rataj?
Agilent reported that director Sue H. Rataj received 2,158 shares of common stock as a fully vested stock award. This was a compensation-related grant, not an open-market purchase or sale, and increased her direct holdings to 23,617 shares.
Was the Agilent (A) Form 4 transaction an open-market buy or sell?
The Form 4 shows a grant of 2,158 Agilent shares to director Sue H. Rataj, not an open-market buy or sale. It is coded as an award acquisition, reflecting routine non-employee director compensation fully vested at the time of grant.
At what price was Sue H. Rataj’s Agilent (A) stock award recorded?
The 2,158-share award to Sue H. Rataj was recorded at $111.75 per share. This price is the transaction value reported for the grant on the Form 4 and is used to calculate the award’s total reported value, not a trade execution price.
What does the footnote on Sue H. Rataj’s Agilent (A) stock grant explain?
The footnote explains the shares were acquired from an award of Agilent common stock for non-employee directors. It clarifies the award is fully vested upon grant, confirming these shares are immediately owned and not subject to additional vesting conditions.